Epstein-Barr virus nuclear antigen 3A protein regulates CDKN2B transcription via interaction with MIZ-1

Nucleic Acids Research

Volumn 42, Issue 15, 2014, Pages 9700-9716

  Bazot, Quentin ^a,b,h   Deschamps, Thibaut ^a,b   Tafforeau, Lionel ^a,b,c,g   Siouda, Maha ^d   Leblanc, Pascal ^b,e   Harth Hertle, Marie L ^f   Rabourdin Combe, Chantal ^a,b,c   Lotteau, Vincent ^a,b,c   Kempkes, Bettina ^f   Tommasino, Massimo ^d   Gruffat, Henri ^a,b   Manet, Evelyne ^a,b  

^a CENTRE INTERNATIONAL DE RECHERCHE EN INFECTIOLOGIE   (France)

^b CNRS   (France)

^c UNIVERSITÉ DE LYON   (France)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^e Univ Claude Bernard   (France)

^f INSTITUTE OF EPIDEMIOLOGY   (Germany)

^g UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^h IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2B; EPSTEIN BARR VIRUS ANTIGEN 3A PROTEIN; EPSTEIN BARR VIRUS ANTIGEN 3B PROTEIN; EPSTEIN BARR VIRUS ANTIGEN 3C PROTEIN; MYC INTERACTING ZINC FINGER PROTEIN 1; NUCLEOPHOSMIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN; ALCOHOL DEHYDROGENASE; C-TERMINAL BINDING PROTEIN; DNA BINDING PROTEIN; EBNA-3A ANTIGEN; EBNA-3B ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN; HISTONE; KRUPPEL LIKE FACTOR; MYC PROTEIN; NUCLEAR PROTEIN; REPRESSOR PROTEIN; ZBTB17 PROTEIN, HUMAN;

AMINO TERMINAL SEQUENCE; ARTICLE; CDKN2B GENE; COMPLEX FORMATION; CONTROLLED STUDY; DNA PROBE; DOWN REGULATION; EPSTEIN BARR VIRUS; GENE ACTIVATION; GENE REPRESSION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION; BIOSYNTHESIS; CELL NUCLEUS; CHEMISTRY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HEK293 CELL LINE; HELA CELL LINE; HUMAN; METABOLISM; PROTEIN DOMAIN;

ALCOHOL OXIDOREDUCTASES; CELL NUCLEUS; CYCLIN-DEPENDENT KINASE INHIBITOR P15; DNA-BINDING PROTEINS; DOWN-REGULATION; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENE EXPRESSION REGULATION; HEK293 CELLS; HELA CELLS; HISTONES; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTO-ONCOGENE PROTEINS C-MYC; REPRESSOR PROTEINS; TRANSCRIPTION, GENETIC;

EID: 84920997103     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku697     Document Type: Article

References (84)

1. Crawford, D.H. (2001) Biology and disease associations of Epstein-Barr virus. Philos. Trans. R. Soc. Lond. B. Biol. Sci., 356, 461-473.
2. Kieff, E. and Rickinson, A.B. (2007) Epstein Barr virus and its replication. Fields, Knipe & Howley (). Fields Virology. 5th (edn). Wolters Kluwer/Lippincott Williams & Wilkins Philadelphia, 2063-2654.
3. Cai, X., Schafer, A., Lu, S., Bilello, J.P., Desrosiers, R.C., Edwards, R., Raab-Traub, N. and Cullen, B.R. (2006) Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog., 2, e23.
4. Tomkinson, B., Robertson, E. and Kieff, E. (1993) Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J. Virol., 67, 2014-2025.
5. Maruo, S., Johannsen, E., Illanes, D., Cooper, A. and Kieff, E. (2003) Epstein-Barr Virus nuclear protein EBNA3A is critical for maintaining lymphoblastoid cell line growth. J. Virol., 77, 10437-10447.
6. Maruo, S., Wu, Y., Ishikawa, S., Kanda, T., Iwakiri, D. and Takada, K. (2006) Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells. Proc. Natl. Acad. Sci. U.S.A., 103, 19500-19505.
7. Hertle, M.L., Popp, C., Petermann, S., Maier, S., Kremmer, E., Lang, R., Mages, J. and Kempkes, B. (2009) Differential gene expression patterns of EBV infected EBNA-3A positive and negative human B lymphocytes. PLoS Pathog., 5, e1000506.
8. Yi, F., Saha, A., Murakami, M., Kumar, P., Knight, J.S., Cai, Q., Choudhuri, T. and Robertson, E.S. (2009) Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities. Virology, 388, 236-247.
9. Knight, J.S., Sharma, N. and Robertson, E.S. (2005) Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase. Proc. Natl. Acad. Sci. U.S.A., 102, 18562-18566.
10. Knight, J.S., Sharma, N. and Robertson, E.S. (2005) SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen. Mol. Cell. Biol., 25, 1749-1763.
11. Knight, J.S., Sharma, N., Kalman, D.E. and Robertson, E.S. (2004) A cyclin-binding motif within the amino-terminal homology domain of EBNA3C binds cyclin A and modulates cyclin A-dependent kinase activity in Epstein-Barr virus-infected cells. J. Virol., 78, 12857-12867.
12. Parker, G.A., Crook, T., Bain, M., Sara, E.A., Farrell, P.J. and Allday, M.J. (1996) Epstein-Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7. Oncogene, 13, 2541-2549.
13. Hickabottom, M., Parker, G.A., Freemont, P., Crook, T. and Allday, M.J. (2002) Two non-consensus sites in the Epstein-Barr virus oncoprotein EBNA3A co-operate to bind the co-repressor CtBP. J. Biol. Chem., 277, 47197-47204.
14. Touitou, R., Hickabottom, M., Parker, G., Crook, T. and Allday, M.J. (2001) Physical and functional interactions between the corepressor CtBP and the Epstein-Barr virus nuclear antigen EBNA3C. J. Virol., 75, 7749-7755.
15. Anderton, E., Yee, J., Smith, P., Crook, T., White, R.E. and Allday, M.J. (2008) Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma. Oncogene, 27, 421-433.
16. Skalska, L., White, R.E., Franz, M., Ruhmann, M. and Allday, M.J. (2010) Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP. PLoS Pathog., 6, e1000951.
17. Skalska, L., White, R.E., Parker, G.A., Sinclair, A.J., Paschos, K. and Allday, M.J. (2013) Induction of p16(INK4a) is the major barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines. PLoS Pathog., 9, e1003187.
18. Marshall, D. and Sample, C. (1995) Epstein-Barr virus nuclear antigen 3C is a transcriptional regulator. J. Virol., 69, 3624-3630.
19. Bain, M., Watson, R.J., Farrell, P.J. and Allday, M.J. (1996) Epstein-Barr virus nuclear antigen 3C is a powerful repressor of transcription when tethered to DNA. J. Virol., 70, 2481-2489.
20. Waltzer, L., Perricaudet, M., Sergeant, A. and Manet, E. (1996) Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-Jk-EBNA2-activated transcription by inhibiting the binding of RBP-Jk to DNA. J. Vi rol., 70, 5909-5915.
21. Bourillot, P.-Y., Waltzer, L., Sergeant, A. and Manet, E. (1998) Transcriptional repression by the Epstein-Barr virus EBNA3A protein tethered to DNA does not require RBP-Jk. J. Gen. Virol., 79, 363-370.
22. Cludts, I. and Farrell, P.J. (1998) Multiple functions within the Epstein-Barr virus EBNA-3A protein. J. Virol., 72, 1862-1869.
23. Cotter, M.A. and Robertson, E.S. (2000) Modulation of histone acetyltransferase activity through interaction of epstein-barr nuclear antigen 3C with prothymosin alpha. Mol. Cell. Biol., 20, 5722-5735.
24. Subramanian, C., Hasan, S., Rowe, M., Hottiger, M., Orre, R. and Robertson, E.S. (2002) Epstein-Barr virus nuclear antigen 3C and prothymosin alpha interact with the p300 transcriptional coactivator at the CH1 and CH3/HAT domains and cooperate in regulation of transcription and histone acetylation. J. Virol., 76, 4699-4708.
25. Radkov, S.A., Touitou, R., Brehm, A., Rowe, M., West, M., Kouzarides, T. and Allday, M.J. (1999) Epstein-Barr virus nuclear antigen 3C interacts with histone deacetylase to repress transcription. J. Virol., 73, 5688-5697.
26. Knight, J.S., Lan, K., Subramanian, C. and Robertson, E.S. (2003) Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human B-cell lines. J. Virol., 77, 4261-4272.
27. Paschos, K., Parker, G.A., Watanatanasup, E., White, R.E. and Allday, M.J. (2012) BIM promoter directly targeted by EBNA3C in polycomb-mediated repression by EBV. Nucleic Acids Res., 40, 7233-7246.
28. Young, P., Anderton, E., Paschos, K., White, R. and Allday, M.J. (2008) Epstein-Barr virus nuclear antigen (EBNA) 3A induces the expression of and interacts with a subset of chaperones and co-chaperones. J. Gen. Virol., 89, 866-877.
29. McClellan, M.J., Khasnis, S., Wood, C.D., Palermo, R.D., Schlick, S.N., Kanhere, A.S., Jenner, R.G. and West, M.J. (2012) Downregulation of integrin receptor-signaling genes by Epstein-Barr virus EBNA 3C via promoter-proximal and -distal binding elements. J. Virol., 86, 5165-5178.
30. Zhao, B., Mar, J.C., Maruo, S., Lee, S., Gewurz, B.E., Johannsen, E., Holton, K., Rubio, R., Takada, K., Quackenbush, J. et al. (2010) Epstein-Barr virus nuclear antigen 3C regulated genes in lymphoblastoid cell lines. Proc. Natl. Acad. Sci. U.S.A., 108, 337-342.
31. Harth-Hertle, M.L, Scholz, B.A., Erhard, F., Glaser, L.V., Dölken, L., Zimmer, R. and Kempkes, B. (2013) Inactivation of intergenic enhancers by EBNA3A initiates and maintains polycomb signatures across a chromatin domain encoding CXCL10 and CXCL9. PLoS Pathog., 9, e1003638.
32. Jiang, S., Willox, B., Zhou, H., Holthaus, A.M., Wang, A., Shi, T.T., Maruo, S., Kharchenko, P.V., Johannsen, E.C., Kieff, E. et al. (2014) Epstein-Barr virus nuclear antigen 3C binds to BATF/IRF4 or SPI1/IRF4 composite sites and recruits Sin3A to repress CDKN2A. Proc. Natl. Acad. Sci. U.S.A., 111, 421-426.
33. McClellan, M.J., Wood, C.D., Ojeniyi, O., Cooper, T.J., Kanhere, A., Arvey, A., Webb, H.M., Palermo, R.D., Harth-Hertle, M.L., Kempkes, B. et al. (2013) Modulation of enhancer looping and differential gene targeting by Epstein-Barr virus transcription factors directs cellular reprogramming. PLoS Pathog., 9, e1003636.
34. Le Roux, A., Kerdiles, B., Walls, D., Dedieu, J.F. and Perricaudet, M. (1994) The Epstein-Barr virus nuclear antigens EBNA-3A, 3B, 3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter. Virology, 205, 596-602.
35. Radkov, S.A., Bain, M., Farrell, P.J., West, M., Rowe, M. and Allday, M.J. (1997) Epstein-Barr virus EBNA3C represses Cp, the major promoter for EBNA expression, but has no effect on the promoter of the cell gene CD21. J. Virol., 71, 8552-8562.
36. Peukert, K., Staller, P., Schneider, A., Carmichael, G., Hanel, F. and Eilers, M. (1997) An alternative pathway for gene regulation by Myc. EMBO J., 16, 5672-5686.
37. Staller, P., Peukert, K., Kiermaier, A., Seoane, J., Lukas, J., Karsunky, H., Möröy, T., Bartek, J., Massagué, J., Hänel, F. et al. (2001) Repression of p15INK4b expression by Myc through association with Miz-1. Nat. Cell Biol., 3, 392-399.
38. Wanzel, M., Russ, A.C., Kleine-Kohlbrecher, D., Colombo, E., Pelicci, P.G. and Eilers, M. (2008) A ribosomal protein L23-nucleophosmin circuit coordinates Mizl function with cell growth. Nat. Cell Biol., 10, 1051-1061.
39. Seoane, J., Pouponnot, C., Staller, P., Schader, M., Eilers, M. and Massague, J. (2001) TGFbeta infuences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Nat. Cell Biol., 3, 400-408.
40. Seoane, J., Le, H.-V. and Massagué, J. (2002) Myc suppression of the p21(Cip1) Cdk inhibitor infuences the outcome of the p53 response to DNA damage. Nature, 419, 729-734.
41. Adhikary, S. and Eilers, M. (2005) Transcriptional regulation and transformation by Myc proteins. Nat. Rev. Mol. Cell Biol., 6, 635-645.
42. Phan, R.T., Saito, M., Basso, K., Niu, H. and Dalla-Favera, R. (2005) BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells. Nat. Immunol., 6, 1054-1060.
43. Saito, M., Novak, U., Piovan, E., Basso, K., Sumazin, P., Schneider, C., Crespo, M., Shen, Q., Bhagat, G., Califano, A. et al. (2009) BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma. Proc. Natl. Acad. Sci. U.S.A., 106, 11294-11299.
44. Basu, S., Liu, Q., Qiu, Y. and Dong, F. (2009) Gf-1 represses CDKN2B encoding p15INK4B through interaction with Miz-1. Proc. Natl. Acad. Sci. U.S.A., 106, 1433-1438.
45. Piluso, D., Bilan, P. and Capone, J.P. (2002) Host cell factor-1 interacts with and antagonizes transactivation by the cell cycle regulatory factor Miz-1. J. Biol. Chem., 277, 46799-46808.
46. Herkert, B., Dwertmann, A., Herold, S., Abed, M., Naud, J.F., Finkernagel, F., Harms, G.S., Orian, A., Wanzel, M. and Eilers, M. (2010) The Arf tumor suppressor protein inhibits Miz1 to suppress cell adhesion and induce apoptosis. J. Cell Biol., 188, 905-918.
47. Walhout, A.J., Temple, G.F., Brasch, M.A., Hartley, J.L., Lorson, M.A., van den Heuvel, S. and Vidal, M. (2000) GATEWAY recombinational cloning: application to the cloning of large numbers of open reading frames or ORFeomes. Methods Enzymol., 328, 575-592.
48. Pellet, J., Tafforeau, L., Lucas-Hourani, M., Navratil, V., Meyniel, L., Achaz, G., Guironnet-Paquet, A., Aublin-Gex, A., Caignard, G., Cassonnet, P. et al. (2010) ViralORFeome: an integrated database to generate a versatile collection of viral ORFs. Nucleic Acids Res., 38, D371-D378.
49. Fugger, K., Mistrik, M., Danielsen, J.R., Dinant, C., Falck, J., Bartek, J., Lukas, J. and Mailand, N. (2009) Human Fbh1 helicase contributes to genome maintenance via pro- and anti-recombinase activities. J. Ce l l Biol., 186, 655-663.
50. Hung, L.Y., Chen, H.L., Chang, C.W., Li, B.R. and Tang, T.K. (2004) Identifcation of a novel microtubule-destabilizing motif in CPAP that binds to tubulin heterodimers and inhibits microtubule assembly. Mol. Biol. Cell, 15, 2697-2706.
51. Yang, F., DeBeaumont, R., Zhou, S. and Naar, A.M. (2004) The activator-recruited cofactor/Mediator coactivator subunit ARC92 is a functionally important target of the VP16 transcriptional activator. Proc. Natl. Acad. Sci. U.S.A., 101, 2339-2344.
52. Fricke, B., Heink, S., Steffen, J., Kloetzel, P.M. and Kruger, E. (2007) The proteasome maturation protein POMP facilitates major steps of 20S proteasome formation at the endoplasmic reticulum. EMBO Rep., 8, 1170-1175.
53. Ricci, E.P., Mure, F., Gruffat, H., Decimo, D., Medina-Palazon, C., Ohlmann, T. and Manet, E. (2009) Translation of intronless RNAs is strongly stimulated by the Epstein-Barr virus mRNA export factor EB2. Nucleic Acids Res., 37, 4932-4943.
54. Albers, M., Kranz, H., Kober, I., Kaiser, C., Klink, M., Suckow, J., Kern, R. and Koegl, M. (2005) Automated yeast two-hybrid screening for nuclear receptor-interacting proteins. Mol. Cell. Proteomics, 4, 205-213.
55. Tafforeau, L., Rabourdin-Combe, C. and Lotteau, V. (2012) Virus-human cell interactomes. Methods Mol Biol., 812, 103-120.
56. Juillard, F., Bazot, Q., Mure, F., Tafforeau, L., Macri, C., Rabourdin-Combe, C., Lotteau, V., Manet, E. and Gruffat, H. (2012) Epstein-Barr virus protein EB2 stimulates cytoplasmic mRNA accumulation by counteracting the deleterious effects of SRp20 on viral mRNAs. Nucleic Acids Res., 40, 6834-6849.
57. Vidalain, P.O., Boxem, M., Ge, H., Li, S. and Vidal, M. (2004) Increasing specifcity in high-throughput yeast two-hybrid experiments. Methods, 32, 363-370.
58. Pellet, J., Meyniel, L., Vidalain, P.O., de Chassey, B., Tafforeau, L., Lotteau, V., Rabourdin-Combe, C. and Navratil, V. (2009) pISTil: a pipeline for yeast two-hybrid Interaction Sequence Tags identifcation and analysis. BMC Res. Notes, 2, 220.
59. Young, D.B., Krauer, K., Kienzlz, N. and Sculley, T. (1997) Both A type and B type Epstein-Barr virus nuclear antigen 6 interact with RBP-2N. J. Gen. Virol., 78, 1671-1674.
60. Krauer, K.G., Belzer, D.K., Liaskou, D., Buck, M., Cross, S., Honjo, T. and Sculley, T. (1998) Regulation of interleukin-1b transcription by Epstein-Barr virus involves a number of latent proteins via their interaction with RBP. Virology, 252, 418-430.
61. Cooper, A., Johannsen, E., Maruo, S., Cahir-McFarland, E., Illanes, D., Davidson, D. and Kieff, E. (2003) EBNA3A association with RBP-Jkappa down-regulates c-myc and Epstein-Barr virus-transformed lymphoblast growth. J. Virol., 77, 999-1010.
62. Calderwood, M.A., Venkatesan, K., Xing, L., Chase, M.R., Vazquez, A., Holthaus, A.M., Ewence, A.E., Li, N., Hirozane-Kishikawa, T., Hill, D.E. et al. (2007) Epstein-Barr virus and virus human protein interaction maps. Proc. Natl. Acad. Sci. U.S.A., 104, 7606-7611.
63. Lin, J., Johannsen, E., Robertson, E. and Kieff, E. (2002) Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2. J. Virol, 76, 232-242.
64. Katsanis, N. and Fisher, E.M. (1998) A novel C-terminal binding protein (CTBP2) is closely related to CTBP1, an adenovirus E1A-binding protein, and maps to human chromosome 21q21.3. Genomics, 47, 294-299.
65. Johnson, B.D., Schumacher, R.J., Ross, E.D. and Toft, D.O. (1998) Hop modulates Hsp70/Hsp90 interactions in protein folding. J. Biol. Chem., 273, 3679-3686.
66. Kim, J., Kim, J.H., Lee, S.H., Kim, D.H., Kang, H.Y, Bae, S.H., Pan, Z.Q. and YS, S. (2002) The novel human DNA helicase hFBH1 is an F-box protein. J. Biol. Chem., 277, 24530-24537.
67. Si, J., Yu, X., Zhang, Y. and DeWille, J.W. (2010) Myc interacts with Max and Miz1 to repress C/EBPS promoter activity and gene expression. Mol. Cancer, 9, 92.
68. Do-Umehara, H.C, Chen, C, Urich, D., Zhou, L., Qiu, J., Jang, S., Zander, A., Baker, M.A., Eilers, M., Sporn, PH.S. et al. (2013) Suppression of infammation and acute lung injury by Miz1 via repression of C/EBP-S. Nat. Immunol, 14, 461-469.
69. Yenamandra, S.P., Hellman, U., Kempkes, B., Darekar, S.D., Petermann, S., Sculley, T., Klein, G and Kashuba, E. (2010) Epstein-Barr virus encoded EBNA-3 binds to vitamin D receptor and blocks activation of its target genes. Cell. Mol. Life Sci., 67, 4249-4256.
70. Wanzel, M., Kleine-Kohlbrecher, D., Herold, S., Hock, A., Berns, K., Park, J., Hemmings, B. and Eilers, M. (2005) Akt and 14-3-3eta regulate Miz1 to control cell-cycle arrest after DNA damage. Nat. Cell Biol, 7, 30-41.
71. Herold, S., Wanzel, M., Beuger, V, Frohme, C, Beul, D, Hillukkala, T., Syvaoja, J., Saluz, H.-P, Haenel, F. and Eilers, M. (2002) Negative regulation of the mammalian UV response by Myc through association with Miz-1. Mol. Cell, 10, 509-521.
72. Allday, M.J., Sinclair, A., Parker, G., Crawford, DH. and Farrell, PJ. (1995) Epstein-Barr virus effciently immortalizes human B cells without neutralizing the function of p53. EMBO J., 14, 1382-1391.
73. Allday, M.J., Inman, G.J., Crawford, D.H. and Farrell, PJ. (1995) DNA damage in human B cells can induce apoptosis, proceeding from G1/S when p53 is transactivation competent and G2/M when it is transactivation defective. EMBO J., 14, 4994-5005.
74. Bajaj, B.G., Murakami, M., Cai, Q., Verma, S.C., Lan, K. and Robertson, E.S. (2008) Epstein-Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoprotein. J. Virol., 82, 4082-4090.
75. Yin, X., Giap, C., Lazo, J.S. and Prochownik, E.V. (2003) Low molecular weight inhibitors of Myc-Max interaction and function. Oncogene, 22, 6151-6159.
76. Jin, J., Cai, Y., Yao, T., Gottschalk, A.J., Florens, L., Swanson, S.K., Gutierrez, J.L., Coleman, M.K., Workman, J.L., Mushegian, A. et al. (2005) A mammalian chromatin remodeling complex with similarities to the yeast INO80 complex. J. Biol. Chem., 280, 41207-41212.
77. Douville, J.M., Cheung, D.Y., Herbert, K.L., Moffatt, T. and Wigle, J.T. (2011) Mechanisms of MEOX1 and MEOX2 regulation of the cyclin dependent kinase inhibitors p21 and p16 in vascular endothelial cells. PLoS One, 6, e29099.
78. Borggrefe, T. and Yue, X. (2011) Interactions between subunits of the mediator complex with gene-specifc transcription factors. Semin. Cell Dev. Biol., 22, 759-768.
79. Dolfni, D., Gatta, R. and Mantovani, R. (2012) NF-Y and the transcriptional activation of CCAAT promoters. Crit. Rev. Biochem. Mol. Biol., 47, 29-49.
80. Paschos, K., Smith, P., Anderton, E., Middeldorp, J.M., White, R.E. and Allday, M.J. (2009) Epstein-Barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim. PLoS Pathog., 5, e1000492.
81. Hughes, R., Kristiansen, M., Lassot, I., Desagher, S., Mantovani, R. and Ham, J. (2011) NF-Y is essential for expression of the proapoptotic bim gene in sympathetic neurons. Cell Death Differ., 18, 937-947.
82. Liu, C.D., Chen, Y.L., Min, Y.L., Zhao, B., Cheng, C.P., Kang, M.S., Chiu, S.J., Kieff, E. and Peng, C.W. (2012) The nuclear chaperone nucleophosmin escorts an Epstein-Barr virus nuclear antigen to establish transcriptional cascades for latent infection in human B cells. PLoS Pathog., 8, e1003084.
83. Wiese, K.E., Walz, S., von Eyss, B., Wolf, E., Athineos, D., Sansom, O. and Eilers, M. (2013) The role of MIZ-1 in MYC-dependent tumorigenesis. Cold Spring Harb. Perspect. Med., 3, a014290.
84. Morandell, D., Kaiser, A., Herold, S., Rostek, U., Lechner, S., Mitterberger, M.C., Jansen-Dürr, P., Eilers, M. and Zwerschke, W. (2012) The human papillomavirus type 16 E7 oncoprotein targets Myc-interacting zinc-fnger protein-1. Virology, 422, 242-253.